Apoptotic cell death does not parallel other indicators of liver damage in chronic hepatitis c patients

Journal of Viral Hepatitis

Volumn 7, Issue 3, 2000, Pages 175-183

  Rodrigues, Cecília M P ^a,d   Brites, D ^a   Serejo, F ^b   Costa, A ^c   Ramalho, F ^b   Carneiro De Moura, M ^b  

^a UNIVERSITY OF LISBON   (Portugal)

^b Hepatology Unit   (Portugal)

^c HOSPITAL DE SANTA MARIA   (Portugal)

^d RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

Apoptosis; Chronic hepatitis C; Histological activity index; Liver tests; Serum and liver bile acids

Indexed keywords

CORE PROTEIN;

ADULT; APOPTOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HEPATITIS C; HOST RESISTANCE; HUMAN; LIVER INJURY; LIVER TUMOR; MALE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

ADULT; AGED; APOPTOSIS; BILE ACIDS AND SALTS; BIOLOGICAL MARKERS; BIOPSY; CHENODEOXYCHOLIC ACID; CHROMATOGRAPHY, GAS; DNA FRAGMENTATION; FEMALE; HEPATITIS C, CHRONIC; HISTOLOGICAL TECHNIQUES; HUMANS; LIVER; MALE; MIDDLE AGED;

EID: 0034110523     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2000.00219.x     Document Type: Review

References (52)

1. 1 Saito I, Miyamura T, Ohbayashi A et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 6547-6549.
2. 2 Colombo M, Covini G. Hepatitis C virus and hepatocellular carcinoma. Clin Exp Rheunmatol 1995; 13: S23-S27.
3. 3 Roberts J, Searle J, Cooksley W. Histological patterns of prolonged hepatitis C infection. Gastroenterol Jpn 1993; 28: S37-S41.
4. 4 Podda M, Ghezzi C, Battezzati PM, Crosignani A, Zuin M, Roda A. Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis. Gastroenterology 1990; 98: 1044-1050.
5. 5 Setchell KDR, Rodrigues CMP, Clerici C, Morelli A, Gartung C, Boyer JL. Bile acid levels in rat and human liver and in hepatocyte nuclei. Gastroenterology 1997; 112: 226-235.
6. 6 Rodrigues CMP, Fan G, Ma X, Kren BT, Steer CJ. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 1998; 101: 2790-2799.
7. 7 Rodrigues CMP, Fan G, Wong P, Kren BT. Steer CJ. Ursodeoxycholic acid modulates mitochondrial transmembrane potential and reactive oxygen species production in bile acid-induced apoptosis. Mol Med 1998; 4: 165-178.
8. 8 Patel T, Bronk S. Gores G. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest 1994; 94: 2183-2192.
9. 9 Zhu N, Khoshnan A, Schneider R. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 1998; 72: 3691-3697.
10. 10 Gonzalez-Amaro R, Garcia-Monzon C, Garcia-Buey L et al. Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med 1994; 179: 841-848.
11. 11 Hussain MJ, Mustafa A, Gallati H, Mowat AP, Mieli-Vergani G, Vergani D. Cellular expression of tumor necrosis factor-alpha and interferon-gamma in the liver biopsies of children with chronic liver disease. J Hepatol 1994; 31: 816-821.
12. 12 Larrea E, Garcia N, Qian C, Civeira MP, Prieto J. Tumor necrosis factor alpha gene expression and the response to Interferon in chronic hepatitis C. Hepatology 1996; 23: 210-217.
13. 13 Ray RB, Meyer K, Steele R, Shrivastava A. Aggarwal BB, Ray R. Inhibition of tumor necrosis factor (TNF-α)-mediated apoptosis by hepatitis C virus core protein. J Biol Chem 1998; 273: 2256-2265.
14. 14 Ray RB, Steele R, Meyer K, Ray R. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem 1997; 272: 10983-10986.
15. 15 Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
16. 16 Rodrigues CMP, Setchell KDR. Performance characteristics of reversed-phase bonded silica cartridges for serum bile acid extraction. Biomed Chromatogr 1996: 10: 1-5.
17. 17 Greim H, Czygan P, Schaffner F, Popper H. Determination of bile acids in needle biopsies of human liver. Biochein Med 1973; 8: 280-286.
18. 18 Setchell KDR, Lawson AM, Tanida N, Sjövall J. General methods for the analysis of metabolic profiles of bile acids and related compounds in feces. J Lipid Res 1983; 24: 1085-1100.
19. 19 Hirano Y, Miyazaki H, Higashidate S, Nakayama F. Analysis of 3-sulfated and nonsulfated bile acids by one-step hydrolysis and high performance liquid chromatography. J Lipid Res 1987; 28: 1524-1529.
20. 20 Nair PP, Garcia CC. A modified gas-liquid Chromatographic procedure for the rapid determination of bile acids in biological fluids. Anal Biochem 1969: 29: 164-166.
21. 21 Almé B, Bremmelgaard A, Sjövall J, Thomassen P. Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatography-mass spectrometry. J Lipid Res 1977; 18: 339-362.
22. 22 Fales HM, Jaouni JM, Babashak JF. Simple device for preparing ethereal diazomethane without resorting to co-distillation. Anal Chem 1973; 45: 2302-2303.
23. 23 Blau K, King GS. Handbook of Derivatives for Chromatography. London: Heyden & Son, 1978.
24. 24 Axelson M, Sjövall. Separation and computerized gas chromatography-mass spectrometry of unconjugated neutral steroids in plasma. J Steroid Biochem 1974; 5: 733-738.
25. 25 Patel TC, Gores GJ. Apoptosis and hepatobiliary disease. Hepatology 1995; 21: 1725-1741.
26. 26 Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
27. 27 Que FG, Gores GJ. Cell death by apoptosis: basic concepts and disease relevance for the gastroenterologist. Gastroenterology 1996; 110: 1238-1243.
28. 28 Henkart PA. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1994; 1: 343-346.
29. 29 Kägi D, Vignaux F, Ledermann B et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994; 265: 528-530.
30. 30 Kägi D, Ledermann B, Burki K et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-delicient mice. Nature 1994; 369: 31-37.
31. 31 Heusel JW, Wesselschmidt RL, Shresta S, Russell JH. Ley TJ. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994; 76: 977-987.
32. 32 Ferenbach DA, Haydon GH, Rae F, Malcomson RD, Harrison DJ. Alteration in mRNA levels of Fas splice variants in hepatitis C-infected liver. J Pathol 1997; 183: 299-304.
33. 33 Hayashi N, Mita E. Fas system and apoptosis in viral hepatitis. J Gastroenterol Hepatol 1997: 12: S223-S226.
34. 34 Ruggieri A, Harada T, Matsuura Y, Miyamura T. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 1997; 229: 68-76.
35. 35 Hiramatsu N, Hayashi N, Katayama K et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 1994; 19: 1354-1359.
36. 36 Mochizuki K, Hayashi N, Hiramatsu N et al. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J Hepatol 1996; 24: 1-7.
37. 37 Reed J. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994: 124: 1-6.
38. 38 Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248: 76-79.
39. 39 Wang XW. Forrester K. Yeh H. Feitelson MA, Gu J-R, Harris CC. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc NaTl Acad Sci USA 1994; 91: 2230-2234.
40. 40 Muralidhar S, Doninger J. Mendelson E et al. Human cytomegalovirus mtrll oncoprotein binds to p53 and down-regulates p53-activated transcription. J Virol 1996; 70: 8691-8700.
41. 41 Vaux D. Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 1993; 90: 786-789.
42. 42 Williams GT, Smith CA. Molecular regulation of apoptosis: genetic control on cell death. Cell 1993; 74: 777-779.
43. 43 Hsu I, Metcalf R, Sun T, Welsh J, Wang N, Harris C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350: 427-428.
44. 44 Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S. p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res 1992; 52: 6358-6364.
45. 45 Yumoto Y, Hanafusa T, Hada H et al. Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma. J Gastroenterol Hepatol 1995; 10: 179-185.
46. 46 Marusawa H, Hijikata M, Chiba T, Shimotohno K. Hepatitis C virus core protein inhibits Fas-and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol 1999; 73: 4713-4720.
47. 47 Frommel TO, Yong S, Zarling EJ. Immunohistochemical evaluation of Bcl-2 gene family expression in liver of hepatitis C and cirrhotic patients: a novel mechanism to explain the high incidence of hepatocarcinoma in cirrhotics. Am J Gastroenterol 1999; 94: 178-182.
48. 48 Gale M Jr, Kwieciszewski B, Dossett M, Nakao H, Katze MG. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J Virol 1999; 73: 6506-6516.
49. 49 Podevin P, Rosmorduc O, Conti F, Calmus Y, Meier PJ, Poupon R. Bile acids modulate the interferon signalling pathway. Hepatology 1999; 29: 1840-1847.
50. 50 Faubion WA, Guicciardi ME, Miyoshi H et al Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 1999; 103: 137-145.
51. 51 Rodrigues CMP, Ma X, Linehan-Stieers C, Fan G, Kren BT, Steer CJ. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Diff 1999; 6: 842-854.
52. 52 Rodrigues CMP, Steer CJ. Mitochondrial membrane perturbations in cholestasis. J Hepatol 2000: 32: 1 35-141.